Παρακαλώ χρησιμοποιήστε αυτό το αναγνωριστικό για να παραπέμψετε ή να δημιουργήσετε σύνδεσμο προς αυτό το τεκμήριο:
https://hdl.handle.net/20.500.14279/14995
Τίτλος: | Risk prediction tools in cardiovascular disease prevention: A report from the ESC Prevention of CVD Programme led by the European Association of Preventive Cardiology (EAPC) in collaboration with the Acute Cardiovascular Care Association (ACCA) and the Association of Cardiovascular Nursing and Allied Professions (ACNAP) | Συγγραφείς: | Rossello, Xavier Dorresteijn, Jannick An Janssen, Arne Lambrinou, Ekaterini Scherrenberg, Martijn Bonnefoy-Cudraz, Eric Cobain, Mark Piepoli, Massimo F. Visseren, Frank Lj Dendale, Paul |
Major Field of Science: | Medical and Health Sciences | Field Category: | MEDICAL AND HEALTH SCIENCES | Λέξεις-κλειδιά: | Risk prediction;Cardiovascular disease;Patient;Prevention;Risk assessment | Ημερομηνία Έκδοσης: | 1-Οκτ-2019 | Πηγή: | European Journal of Cardiovascular Nursing, 2019, vol. 18, no. 7, pp. 534-544 | Volume: | 18 | Issue: | 7 | Start page: | 534 | End page: | 544 | Περιοδικό: | European Journal of Cardiovascular Nursing | Περίληψη: | Risk assessment and risk prediction have become essential in the prevention of cardiovascular disease. Even though risk prediction tools are recommended in the European guidelines, they are not adequately implemented in clinical practice. Risk prediction tools are meant to estimate prognosis in an unbiased and reliable way and to provide objective information on outcome probabilities. They support informed treatment decisions about the initiation or adjustment of preventive medication. Risk prediction tools facilitate risk communication to the patient and their family, and this may increase commitment and motivation to improve their health. Over the years many risk algorithms have been developed to predict 10-year cardiovascular mortality or lifetime risk in different populations, such as in healthy individuals, patients with established cardiovascular disease and patients with diabetes mellitus. Each risk algorithm has its own limitations, so different algorithms should be used in different patient populations. Risk algorithms are made available for use in clinical practice by means of - usually interactive and online available - tools. To help the clinician to choose the right tool for the right patient, a summary of available tools is provided. When choosing a tool, physicians should consider medical history, geographical region, clinical guidelines and additional risk measures among other things. Currently, the U-prevent.com website is the only risk prediction tool providing prediction algorithms for all patient categories, and its implementation in clinical practice is suggested/advised by the European Association of Preventive Cardiology. | URI: | https://hdl.handle.net/20.500.14279/14995 | ISSN: | 14745151 | DOI: | 10.1177/1474515119856207 | Rights: | © The European Society of Cardiology | Type: | Article | Affiliation: | Centro Nacional de Investigaciones Cardiovasculares (CNIC) Centro de Investigación Biomédica en Red en Enfermedades Cardiovasculares (CIBERCV) University Medical Center Utrecht Jessa Hospital Cyprus University of Technology Hasselt University Hôpital cardiologique de Lyon Imperial College London G da Saliceto Hospital University of Southern California |
Publication Type: | Peer Reviewed |
Εμφανίζεται στις συλλογές: | Άρθρα/Articles |
CORE Recommender
SCOPUSTM
Citations
75
checked on 2 Φεβ 2024
WEB OF SCIENCETM
Citations
20
Last Week
0
0
Last month
0
0
checked on 29 Οκτ 2023
Page view(s)
369
Last Week
1
1
Last month
1
1
checked on 3 Φεβ 2025
Google ScholarTM
Check
Altmetric
Όλα τα τεκμήρια του δικτυακού τόπου προστατεύονται από πνευματικά δικαιώματα